Changes in BMI for respective FTND scores (mean ± standard deviation).

<p>Changes in BMI for respective FTND scores (mean ± standard deviation).</p

Percent change in patient data from pre- to post- smoking cessation: Comparison between patients with lesser versus greater abdominal obesity.

<p>Percent change in patient data from pre- to post- smoking cessation: Comparison between patients with lesser versus greater abdominal obesity.</p

Gender-adjusted regression analysis for the change of BMI.

<p><i>β</i>: Standardized coefficient.</p>a<p>Gender-adjusted.</p

Data on patients before and after successful smoking cessation.

<p>Data are presented as the mean ± SD.</p

Patient data before and 1 year after successful smoking cessation in the lesser (A) and greater (B) abdominal obesity groups.

<p>Patient data before and 1 year after successful smoking cessation in the lesser (A) and greater (B) abdominal obesity groups.</p

Pre- and post-smoking cessation data based on FTND scores.

<p>Data are presented as the mean ± SD.</p>*<p><i>P</i><0.05, **<i>P</i><0.01 vs. before measurement.</p>#<p><i>P</i><0.05 vs. “FTND ≦ 7.0”.</p>†<p>Two-way repeated measures ANOVA (time [before and after] × group).</p

Patient data before smoking cessation: Comparison between patients with smaller versus larger waist circumference changes.

<p>Patient data before smoking cessation: Comparison between patients with smaller versus larger waist circumference changes.</p

Data on patients before and after smoking cessation therapy.

*<p><i>P</i><0.05,</p>**<p><i>P</i><0.01 vs. before smoking cessation therapy.</p>†<p>Two-way repeated measures ANOVA (time [before and after] × group).</p

Distribution of patients for each CHADS₂ and CHA₂DS₂-VASc score.

<p>(A) Patients without oral anticoagulant (OAC). (B) Patients with OAC. SD: standard deviation.</p

Data on patients before smoking cessation therapy.

#<p><i>P</i><0.05,</p>##<p><i>P</i><0.01 vs. “Nicotine Patch”.</p